Beer Ingredient May Slow Alzheimer's, Parkinson's Development
the Psychiatry Advisor take:
Evidence has suggested that oxidative damage to neuronal cells contributes to the development of neurodegenerative diseases. If researchers found a way to protect these cells, it could potentially slow or even prevent the onset of neurodegenerative diseases.
Lately, many studies have focused on the health benefits of wine, but scientists are accumulating evidence that beer could have more health properties than previously thought.
In a new study published in the Journal of Agricultural and Food Chemistry, the researchers have found that a compound in hops, called xanthohumol, has anti-oxidation, cardiovascular protection, and anticancer properties.
The researchers tested the effects of xanthohumol on brain cells. Lab tests showed that the compound was successful in protecting neuronal cells from oxidative damage.
Because xanthohumol has shown protective properties for brain cells, it may be a candidate for the prevention or delaying of neurodegenerative diseases. The current findings are preliminary, but the results are promising. Further studies are needed to determine the safety and efficacy of xanthohumol as a preventative measure or treatment for diseases like Alzheimer’s and Parkinson's.
Compound in Beer May Slow Alzheimer's, Parkinson's Development
The health-promoting perks of wine have attracted the spotlight recently, leaving beer in the shadows, researchers said.
But scientists are discovering new ways in which the latter could be a more healthful beverage than once thought.
Researchers report in ACS' Journal of Agricultural and Food Chemistry that a compound from hops could protect brain cells from damage - and potentially slow the development of disorders such as Alzheimer's and Parkinson's diseases.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- Early Childhood Out-of-Home Placement Associated With Adverse Outcomes in Adulthood
- ADHD Medications Compared for Efficacy, Tolerability in Children and Adults
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Symptoms of Anxiety, Depression Differ Depending on Gender, Race, Ethnicity
- Examining Whether Adjunctive Glutamatergic Medication Further Eases OCD Symptoms
- FDA Permits Marketing of Brain Stimulation Device for OCD
- Antipsychotics Adversely Affect Adiposity and Insulin Sensitivity in Youths
- Know Before You Go: Practicing Medicine Abroad